Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance

Fig. 7

Patient 2 timeline. Depiction of all treatment courses and subsequent outcomes of patient 2, showing the stages from which specimens were derived for analysis. Abbreviations: DNR, daunorubicin; Ara-C, Cytarabine; HiDAC, high-dose Ara-C; MX, mitoxantrone; VP-16, etoposide; HSCT, hematopoietic stem cell transplantation; GO, gemtuzumab ozogamicin; MTX, methotrexate; CAR, chimeric antigen receptor

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us